Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(36:3) | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 184 | pmol/sample |
| - | PE(36:3) | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 269 | pmol/sample |
| - | PE(36:3) | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 238 | pmol/sample |
| - | PE(36:3) | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 165 | pmol/sample |
| - | PE(36:3) | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 146 | pmol/sample |
| - | PE(36:3) | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 205 | pmol/sample |
| - | PE(36:3) | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 163 | pmol/sample |
| - | PE(36:3) | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 229 | pmol/sample |
| - | PE(36:3) | C | 0.0 | BCD100427B001 | 281 | pmol/sample |
| - | PE(36:3) | C | 0.5 | BCD100427B003 | 149 | pmol/sample |
| - | PE(36:3) | C | 1.0 | BCD100427B007 | 343 | pmol/sample |
| - | PE(36:3) | C | 2.0 | BCD100427B011 | 166 | pmol/sample |
| - | PE(36:3) | C | 4.0 | BCD100427B015 | 194 | pmol/sample |
| - | PE(36:3) | C | 8.0 | BCD100427B019 | 147 | pmol/sample |
| - | PE(36:3) | C | 12.0 | BCD100427B023 | 173 | pmol/sample |
| - | PE(36:3) | C | 24.0 | BCD100427B027 | 193 | pmol/sample |
| - | PE(36:3) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 164 | pmol/sample |
| - | PE(36:3) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 160 | pmol/sample |
| - | PE(36:3) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 153 | pmol/sample |
| - | PE(36:3) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 130 | pmol/sample |
| - | PE(36:3) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 214 | pmol/sample |
| - | PE(36:3) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 111 | pmol/sample |
| - | PE(36:3) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 254 | pmol/sample |
| - | PE(36:3) | 25OH-Chol | 0.5 | BCD100427B004 | 307 | pmol/sample |
| - | PE(36:3) | 25OH-Chol | 1.0 | BCD100427B008 | 159 | pmol/sample |
| - | PE(36:3) | 25OH-Chol | 2.0 | BCD100427B012 | 354 | pmol/sample |
| - | PE(36:3) | 25OH-Chol | 4.0 | BCD100427B016 | 175 | pmol/sample |
| - | PE(36:3) | 25OH-Chol | 8.0 | BCD100427B020 | 240 | pmol/sample |
| - | PE(36:3) | 25OH-Chol | 12.0 | BCD100427B024 | 233 | pmol/sample |
| - | PE(36:3) | 25OH-Chol | 24.0 | BCD100427B028 | 178 | pmol/sample |